Market cap
₹299 Mln
Revenue (TTM)
₹9 Mln
P/E Ratio
48.6
P/B Ratio
10.7
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹6 Mln
-
ROE
0.3 %
-
ROCE
27 %
-
Industry P/E
--
-
EV/EBITDA
53.8
-
Debt to Equity
--
-
Book Value
₹0.7
-
EPS
₹0.1
-
Face value
--
-
Shares outstanding
43,891,200
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Anbio Biotechnology
| -74.4 | -22.2 | -76.7 | -84.4 | -- | -- | -- |
|
BSE Sensex
| -9.1 | 1.1 | 1.2 | -4.8 | 5.8 | 6.6 | 10.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Anbio Biotechnology
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated... isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany. Read more
-
Chief Executive Officer
Mr. Michael Lau M.B.A., Ph.D.
-
Chief Executive Officer
Mr. Michael Lau M.B.A., Ph.D.
-
Headquarters
Frankfurt am Main
-
Website
FAQs for Anbio Biotechnology
What is the current share price of Anbio Biotechnology Today?
The share price of Anbio Biotechnology is ₹7.70 (NASDAQ) as of 27-Aug-2026 10:37 EDT. Anbio Biotechnology has given a return of -84.39% in the last 1 years.
What is the current PB & PE ratio of Anbio Biotechnology?
The P/E ratio of Anbio Biotechnology is 48.64 times as on 21-Aug-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
206.13 |
43.77 |
2024 |
-- |
-- |
2023 |
-- |
-- |
2022 |
-- |
-- |
2021 |
-- |
-- |
What is the 52 Week High and Low of Anbio Biotechnology?
The 52-week high and low of Anbio Biotechnology are Rs 51.33 and Rs 6.61 as of 27-Aug-2026.
What is the market cap of Anbio Biotechnology?
Anbio Biotechnology has a market capitalisation of ₹ 299 Mln as on 21-Aug-2026. As per SEBI classification, it is a company.
Should I invest in Anbio Biotechnology?
Before investing in Anbio Biotechnology, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.